Bookbot

Ernst Schering Research Foundation Workshop Supplement - 7: New Concepts in Pathology and Treatment of Autoimmune Disorders

Parámetros

  • 139 páginas
  • 5 horas de lectura

Más información sobre el libro

Autoimmunity, characterized by autoreactive lymphocytes and autoantibodies, is the consequence of a failure to discriminate between self and non-self, and autoimmune diseases are an increasing threat to people living in the industrialized countries. Autoimmune disorders are treatable, but not curable, and patients can face disability at later stages of the disease. Thus, there is a medical and economic need for new concepts and treatments in autoimmune disorders. New concepts and treatments can only be achieved by an interdisciplinary approach bringing together expertise, technologies, and clinical experience. The workshop focused on multiple sclerosis, rheumatoid arthritis and type I diabetes, and discussed conventional drug therapies, gene therapy, cell and tissue transplantation therapies, and first treatments using blood stem cells for reprogramming the patients' immune system.

Compra de libros

Ernst Schering Research Foundation Workshop Supplement - 7: New Concepts in Pathology and Treatment of Autoimmune Disorders, Paolo Pozzilli, Carlo Pozzilli, J.-F. Kapp

Idioma
Publicado en
2001
Encuadernación
(Tapa dura),
Estado del libro
Bueno
Precio
12,99 €

Métodos de pago

Nadie lo ha calificado todavía.Añadir reseña

Título
Ernst Schering Research Foundation Workshop Supplement - 7: New Concepts in Pathology and Treatment of Autoimmune Disorders
Idioma
Inglés
Editorial
Springer
Publicado en
2001
Formato
Tapa dura
Páginas
139
ISBN10
3540414797
ISBN13
9783540414797
Serie
Descripción
Autoimmunity, characterized by autoreactive lymphocytes and autoantibodies, is the consequence of a failure to discriminate between self and non-self, and autoimmune diseases are an increasing threat to people living in the industrialized countries. Autoimmune disorders are treatable, but not curable, and patients can face disability at later stages of the disease. Thus, there is a medical and economic need for new concepts and treatments in autoimmune disorders. New concepts and treatments can only be achieved by an interdisciplinary approach bringing together expertise, technologies, and clinical experience. The workshop focused on multiple sclerosis, rheumatoid arthritis and type I diabetes, and discussed conventional drug therapies, gene therapy, cell and tissue transplantation therapies, and first treatments using blood stem cells for reprogramming the patients' immune system.